Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 6.5B | 4.4B | 4.0B | 2.3B |
Cost of revenue | 2.9B | 2.3B | 2.5B | 1.6B |
Gross profit | 3.5B | 2.1B | 1.5B | 761M |
Operating expense | ||||
Research & development | 375M | 335M | 365M | 348M |
Selling general and admin | 1.2B | 751M | 626M | 708M |
Other operating expenses | — | — | — | — |
Operating income | 1.8B | 827M | 327M | -465M |
Non operating interest income | ||||
Income | 31M | 32M | 39M | 33M |
Expense | 52M | 36M | 60M | 66M |
Other income expense | -7M | -39M | -218M | -135M |
Pretax income | 1.8B | 784M | 88M | -633M |
Tax provision | 422M | 117M | 138M | -114M |
Net income | 1.3B | 656M | -39M | -521M |
Basic EPS | 1.9 | 1.0 | -0.1 | -0.8 |
Diluted EPS | 1.9 | 1.0 | -0.1 | -0.8 |
Basic average shares | 681.7M | 684.9M | 687.3M | 691.1M |
Diluted average shares | 683.1M | 686.6M | 687.3M | 691.1M |
EBITDA | 2.2B | 1.2B | 589M | -132M |
Net income from continuing op. | 1.4B | 667M | -79M | -490M |
Minority interests | -2M | -4M | -2M | -3M |
Preferred stock dividends | — | — | — | — |